Syngene International Ltd
Company Profile
Business description
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
Contact
Jigani Link Road, Biocon SEZ, Biocon Park
Plot No. 2 and 3, IV Phase
Bommasandra Industrial Area
BangaloreKA560 099
INDT: +91 8068918000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2025
Employees
8,146
Stocks News & Analysis
stocks
The 10 best US dividend stocks
stocks
Australian stocks will crush housing over the next decade, one year on
stocks
10 best US blue-chip stocks to buy for the long term
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,577.80 | 21.60 | -0.25% |
| CAC 40 | 7,490.28 | 37.86 | 0.51% |
| DAX 40 | 20,317.10 | 12.84 | -0.06% |
| Dow JONES (US) | 42,635.20 | 106.84 | 0.25% |
| FTSE 100 | 8,319.69 | 68.66 | 0.83% |
| HKSE | 19,240.89 | 38.95 | -0.20% |
| NASDAQ | 19,478.88 | 10.80 | -0.06% |
| Nikkei 225 | 39,605.09 | 375.97 | -0.94% |
| NZX 50 Index | 12,943.74 | 99.37 | -0.76% |
| S&P 500 | 5,918.25 | 9.22 | 0.16% |
| S&P/ASX 200 | 8,329.20 | 19.90 | -0.24% |
| SSE Composite Index | 3,211.39 | 18.77 | -0.58% |